- Home
- PCYO vs BDSX Comparison
PCYO vs BDSX Comparison
Compare PCYO & BDSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCYO
- BDSX
- Stock Information
- Founded
- PCYO 1976
- BDSX 2005
- Country
- PCYO United States
- BDSX United States
- Employees
- PCYO N/A
- BDSX N/A
- Industry
- PCYO Water Supply
- BDSX Precision Instruments
- Sector
- PCYO Utilities
- BDSX Health Care
- Exchange
- PCYO Nasdaq
- BDSX Nasdaq
- Market Cap
- PCYO 248.0M
- BDSX 115.4M
- IPO Year
- PCYO N/A
- BDSX 2020
- Fundamental
- Price
- PCYO $10.69
- BDSX $0.28
- Analyst Decision
- PCYO
- BDSX Strong Buy
- Analyst Count
- PCYO 0
- BDSX 5
- Target Price
- PCYO N/A
- BDSX $1.75
- AVG Volume (30 Days)
- PCYO 41.3K
- BDSX 1.7M
- Earning Date
- PCYO 07-09-2025
- BDSX 08-06-2025
- Dividend Yield
- PCYO N/A
- BDSX N/A
- EPS Growth
- PCYO 118.08
- BDSX N/A
- EPS
- PCYO 0.59
- BDSX N/A
- Revenue
- PCYO $29,911,000.00
- BDSX $74,463,000.00
- Revenue This Year
- PCYO N/A
- BDSX $17.29
- Revenue Next Year
- PCYO N/A
- BDSX $29.33
- P/E Ratio
- PCYO $18.84
- BDSX N/A
- Revenue Growth
- PCYO 58.85
- BDSX 35.76
- 52 Week Low
- PCYO $9.17
- BDSX $0.17
- 52 Week High
- PCYO $14.63
- BDSX $2.04
- Technical
- Relative Strength Index (RSI)
- PCYO 53.11
- BDSX 43.60
- Support Level
- PCYO $10.39
- BDSX $0.25
- Resistance Level
- PCYO $11.16
- BDSX $0.31
- Average True Range (ATR)
- PCYO 0.31
- BDSX 0.02
- MACD
- PCYO 0.07
- BDSX 0.01
- Stochastic Oscillator
- PCYO 59.48
- BDSX 46.91
About PCYO Pure Cycle Corporation
Pure Cycle Corp is a diversified land and water resource development company. The company designs, constructs, manages, operates, and maintains water and wastewater systems. The firm operates in two business segments namely Water and wastewater resource development and Land development. It generates maximum revenue from the Land development segment. The land resource development segment includes all the activities necessary to develop and sell finished lots.
About BDSX Biodesix Inc.
Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Coronavirus Disease 2019 (COVID-19) tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.